Clinical Trial Update: Study of the Effectiveness and Safety of Niaspan ® in the Treatment of Lipid Abnormalities in Latin America

View source ↗

Summary

A completed clinical trial evaluating the effectiveness and safety of Niaspan for lipid abnormalities in Latin America; results were posted in 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hyperlipidemia

Drugs mentioned

• Niaspan (niacin (nicotinic acid))

Snippet

Sponsor: Abbott | Conditions: Cardiovascular Diseases | Status: COMPLETED | Results posted: 2014-06-06